DDR-TRK-1

产品编号 T10984Cas号 1934246-19-1

DDR-TRK-1 是 DDR1的一个选择性抑制剂，其 IC50 值为 9.4 nM。DDR-TRK-1 也抑制 TRK 激酶家族。

为众多的药物研发团队赋能，

让新药发现更简单！

产品编号 T10984Cas号 1934246-19-1

DDR-TRK-1 是 DDR1的一个选择性抑制剂，其 IC50 值为 9.4 nM。DDR-TRK-1 也抑制 TRK 激酶家族。

大包装 & 定制

加入购物车

该分子属于定制产品。陶术拥有优秀的合成团队，经验和能力，可以为您提供高性价比的产品。但由于客观因素，研发中会存在小概率合成不成功的情况，还请理解，如您有任何问题，欢迎咨询，我们将竭诚为您服务。

实验操作小课堂

选择批次:

纯度:99.86%

联系我们获取更多批次信息

资源下载

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

生物活性

产品描述	DDR-TRK-1 is a selective discoid domain receptor 1 (DDR1) inhibitor with IC50 value of 9.4 nM. DDR-TRK-1 also inhibits the TRK family.
靶点活性	DDR1:9.4 nM
体外活性	DDR-TRK-1 is a promising candidate with an IC50 value of 9.4 nM relative to DDR1. DDR-TRK-1 also exhibited reasonable pharmacokinetic (PK) properties. At an oral dose of 20 mg/kg in rats, the oral bioavailability was 66.8%, and the T1/2 value was 1.25 h. However, the area under the concentration-time curve (AUC) value of DDR-TRK-1 in mice was significantly higher than that in rats, indicating that its absorption performance in mice was good. By determining the binding affinity of DDR1-IN-3 and DDR1 protein, the inhibitory effect of DDR1 on DDR1-IN-3 can be further verified. The results show that DDR-TRK-1 is closely bound to DDR1, and the binding constant (Kd) value is 4.7 nM[1].
体内活性	DDR-TRK-1 can prevent blm-induced pathological changes in a dose-dependent manner. These results agree with the expression levels of fibrosis markers in the lung tissue, including lysates, including fibronectin and α-smooth muscle actin (SMA). Further analysis also showed that the use of DDR-TRK-1 resulted in a dose-dependent inhibition of hydroxyproline content, a unique amino acid found in collagen. The above data indicate that DDR-TRK-1 has good therapeutic potential for blm-induced pulmonary fibrosis[1].

化学信息

储存&溶解度

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

溶解度信息

DMSO: 50 mg/mL (101.52 mM)

溶液配制表

DMSO